Biorestorative Therapies, Inc. (BRTX) files for 508.6K share offering by selling stockholders Nov 18, 2025 04:47PM
BioRestorative Therapies, Inc. (BRTX) Tops Q3 EPS by 5c Nov 12, 2025 05:39PM
Biorestorative Therapies, Inc. (BRTX) Reports Compelling Preliminary Data for BRTX-100 Jun 13, 2025 07:46AM
BioRestorative Therapies, Inc. (BRTX) Misses Q1 EPS by 38c May 14, 2025 05:51PM
Biorestorative Therapies, Inc. (BRTX) recieves FDA Fast Track designation for BRTX-100 Apr 16, 2025 10:49AM


Apr 10, 2025 09:15AM Biorestorative Therapies, Inc. (BRTX) Confirms No Material Impact from Reciprocal Tariffs
Feb 20, 2025 08:48AM BioRestorative (BRTX) Receives FDA Fast Track Designation for BRTX-100 Chronic Lumbar Disc Disease Program
Nov 13, 2024 05:17PM BioRestorative Therapies, Inc. (BRTX) Tops Q3 EPS by 31c
Aug 14, 2024 05:08AM BioRestorative Therapies Inc. (BRTX) PT Raised to $18 at Roth/MKM
Aug 13, 2024 05:08PM BioRestorative Therapies, Inc. (BRTX) Tops Q2 EPS by 5c
Jun 27, 2024 04:07PM Roth/MKM Reiterates Buy Rating on BioRestorative Therapies Inc. (BRTX)
Jun 12, 2024 02:48PM Roth/MKM Reiterates Buy Rating on BioRestorative Therapies Inc. (BRTX)